The company was founded in Fribourg following the acquisition of RHONE-POULENC RORER products by Jean-Pierre Grave. From its inception, the company was oriented toward emerging markets, with a particular focus on the Maghreb and West Africa.
Purchased by Philippe Bellegarde. To this day, it remains a “family-run” business oriented toward exports outside the European Economic Community.
Under the leadership of its Management, the FRILAB Group expanded its activities through the acquisition of new products and the establishment of licensing agreements with prestigious partner laboratories. Starting from West African territories, the geographical scope extended to Portuguese-speaking and English speaking countries.
Acquisition of NEITUM Laboratories in Lyon, which became Frilab France Laboratories in Paris in 2018. FRILAB France Laboratories currently hold our Marketing Authorizations (MA) for the countries of origin and market them within the EEC.
Opening of our representative office in Lisbon to manage activities in Portuguese speaking Africa.
This promotional subsidiary hosts 65% of Africa’s medical representatives, including its unique network of hospital representatives in West Africa.
To support its strong growth, the FRILAB Group strengthened its local structure by creating a HUB bringing together regulatory activities and commercial coordination.
At the headquarters in Geneva, general resources have been continuously reinforced over the years to match the company’s uninterrupted growth, particularly in relation to new activities in the CIS region and the Middle East.
The company is well positioned to continue on a path of sustained growth supported by the acquisition of new products, while preserving its licensing strategy.
FRILAB Laboratories place scientific rigor, patient safety, and professional integrity at the heart of every action we take. Based in Switzerland and committed to supporting our partners around the world, we rely on strong values that guide our development and ensure the quality of our exported products.
We are committed to producing and marketing pharmaceutical solutions that meet the strictest standards.
The Swiss signature of our products is synonymous with reliability, precision, and consistency.
Patient safety is our absolute priority.
FRILAB Laboratories fully assumes its role in protecting public health.
As an exporting company, FRILAB Laboratories ensures:
We build longlasting relationships based on respect and trust.
Our decisions are never guided by convenience, but by ethics.
We believe that trust is the foundation of all collaboration.
Aware of our impact, we implement responsible initiatives:
We innovate to protect both health… and the planet.
As an exporting laboratory, we cultivate strong, trustbased relationships:
We move forward together to ensure the success of your projects.
Some companies are renowned for their projects, and others for the spirit that drives them.
FRILAB Laboratories remains a family-owned business, committed to producing in Europe and developing healthcare solutions that are accessible to all while also meeting European quality standards. FRILAB Laboratories cultivates a mission that truly matters.
Every day, our teams are guided by a unique DNA:
This extra spirit is priceless, as it naturally strengthens our attractiveness.
The pride our teams take in serving healthcare professionals—and therefore patients—enhances our reputation.
FRILAB Laboratories promote collective intelligence as a driver of our corporate culture.
This is reflected in the following key principles:
At FRILAB Laboratories, our mission is to develop, manufacture and supply reliable and accessible pharmaceutical solutions while complying with international quality standards.
We are committed to:
✔ Ensuring quality at every stage
Guaranteeing manufacturing based on active ingredients that meet European standards and implementing Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) to deliver standardized, effective products.
✔ Acting as a trusted partner across our markets
Supporting our distributors and clients in more than 40 countries through recognized regulatory, logistical and scientific expertise.
✔ Promoting a responsible pharmaceutical industry
Integrating sustainable, ethical and transparent practices across all our activities: sourcing, manufacturing, and human relations, both internally and with our partners.
FRILAB Laboratories looks to the future with a clear vision: becoming a benchmark in pharmaceutical quality.
Our ambitions are built around four key pillars:
1. Expanding our international presence
Strengthening our network of partners and extending our commercial footprint into new markets, while consolidating existing relationships.
We aim for controlled growth grounded in operational excellence and regulatory compliance.
Continuous training for our sales force is a central element of this ambition.
2. Strengthening our product portfolio
Expanding our product ranges by integrating new pharmaceutical specialties and products under exclusive licensing agreements.
Our objective: meeting the needs of a growing number of patients across essential and targeted therapeutic areas—while maintaining continuity for longstanding medicinal products.
3. Innovating sustainably
Continuing our investments in the development of targeted therapeutic solutions and in the automation of our processes to enhance agility and competitiveness.
FRILAB Laboratories aims to become a model of pragmatic innovation, serving both quality and therapeutic effectiveness.
4. Being a model of responsibility and transparency
Upholding Human Life by promoting a more sustainable pharmaceutical industry—respectful of the environment, social standards and international ethical requirements.
We place transparency, safety and accountability at the core of all decisions by implementing our ethical code.
Building a future in which pharmaceutical quality contributes to improved global health by enabling access to safe, effective and responsible therapeutic solutions.
FRILAB Laboratories aspires to become a partner of choice for healthcare professionals, distributors and public institutions worldwide.
1. Overview
FRILAB Laboratories is an organization specialized in supporting, guiding and ensuring the compliance of stakeholders in the pharmaceutical, parapharmaceutical and humanitarian sectors.
Based in Geneva, the headquarters coordinates all transversal functions necessary for the smooth operation of the group and the support of international partners.
2. General Services – Based in Geneva
General Services bring together the central departments of FRILAB Laboratories, guaranteeing quality, compliance and coherence in strategic development.
2.1 Finance – Legal – & Trademark Protection
Across all countries in Africa, the Middle East and beyond, this department ensures:
2.2 Marketing & Training
Responsible for the group’s visibility and consistency:
FRILAB Medical Representatives
Beyond their essential functions, our medical representatives must:
Our experienced field collaborators, specialized in both community and hospital networks, embody the company’s values: pragmatic, curious professionals who remain attentive to the realities of their environment. This allows FRILAB to continuously adapt to the needs of its medical partners and ensure consistent access to healthcare.
2.3 Regulatory Affairs & Pharmacovigilance
Indispensable pillars to ensure safety and compliance:
3. Our Commercial Partners
FRILAB Laboratories supports a wide range of professional stakeholders:
Private Partners (Wholesalers & Importers)
Purchasing Centers
Non-Governmental Organizations (NGOs)
FRILAB is accredited by several European NGOs. As such, we supply products that meet international requirements.